The Role of Azithromycin in Patients with Cystic Fibrosis
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 11 (2) , 108-114
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- AZITHROMYCIN INCREASES CHLORIDE EFFLUX FROM CYSTIC FIBROSIS AIRWAY EPITHELIAL CELLSExperimental Lung Research, 2009
- Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2008
- Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trialThorax, 2006
- Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global ApproachAntimicrobial Agents and Chemotherapy, 2006
- Anti‐inflammatory effects of macrolides in lung disease*Pediatric Pulmonology, 2001
- Long-term azithromycin may improve lung function in children with cystic fibrosisThe Lancet, 1998
- Diffuse panbronchiolitis and cystic fibrosis: East meets West.Thorax, 1994
- Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibioticsJournal of Antimicrobial Chemotherapy, 1993
- The changing epidemiology of cystic fibrosisThe Journal of Pediatrics, 1993
- Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neotrophilsJournal of Antimicrobial Chemotherapy, 1989